Srikanth Vallurupalli
Concepts (296)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Coronary Artery Disease | 12 | 2024 | 294 | 4.300 |
Why?
| Atrial Fibrillation | 5 | 2022 | 200 | 2.370 |
Why?
| Percutaneous Coronary Intervention | 9 | 2022 | 307 | 2.360 |
Why?
| Ventricular Function, Right | 6 | 2025 | 42 | 2.270 |
Why?
| Ventricular Dysfunction, Right | 3 | 2023 | 33 | 2.250 |
Why?
| Echocardiography | 13 | 2025 | 415 | 2.130 |
Why?
| Aortic Valve Stenosis | 5 | 2021 | 76 | 2.110 |
Why?
| Myocardial Infarction | 6 | 2025 | 412 | 2.000 |
Why?
| Stents | 8 | 2022 | 351 | 1.990 |
Why?
| Angioplasty, Balloon, Coronary | 4 | 2018 | 136 | 1.960 |
Why?
| Echocardiography, Doppler | 3 | 2025 | 57 | 1.540 |
Why?
| Endocarditis | 2 | 2022 | 31 | 1.320 |
Why?
| Aortic Valve | 3 | 2020 | 123 | 1.290 |
Why?
| Thrombocytopenia | 2 | 2022 | 89 | 1.280 |
Why?
| Treatment Outcome | 27 | 2025 | 5422 | 1.260 |
Why?
| Electrocardiography | 6 | 2024 | 268 | 1.220 |
Why?
| Humans | 71 | 2025 | 52483 | 1.200 |
Why?
| Heart Failure | 7 | 2025 | 565 | 1.200 |
Why?
| Heart Ventricles | 6 | 2025 | 267 | 1.140 |
Why?
| Fractional Flow Reserve, Myocardial | 4 | 2022 | 127 | 1.110 |
Why?
| Ischemic Attack, Transient | 2 | 2018 | 57 | 1.060 |
Why?
| Anemia | 2 | 2025 | 74 | 0.960 |
Why?
| Veterans | 2 | 2022 | 583 | 0.950 |
Why?
| Pulmonary Artery | 2 | 2025 | 150 | 0.930 |
Why?
| Stroke | 3 | 2021 | 512 | 0.920 |
Why?
| Exercise Test | 3 | 2024 | 141 | 0.850 |
Why?
| Coronary Stenosis | 2 | 2021 | 98 | 0.830 |
Why?
| Risk Factors | 17 | 2025 | 3889 | 0.830 |
Why?
| Coronary Angiography | 9 | 2022 | 367 | 0.820 |
Why?
| Thrombosis | 3 | 2024 | 253 | 0.780 |
Why?
| Electric Countershock | 1 | 2022 | 30 | 0.760 |
Why?
| Endocarditis, Bacterial | 1 | 2022 | 43 | 0.750 |
Why?
| Atrial Appendage | 1 | 2021 | 14 | 0.740 |
Why?
| Kidney Diseases | 3 | 2021 | 220 | 0.740 |
Why?
| Catheter Ablation | 2 | 2021 | 126 | 0.720 |
Why?
| Retrospective Studies | 16 | 2023 | 6607 | 0.720 |
Why?
| Anticholesteremic Agents | 1 | 2021 | 31 | 0.710 |
Why?
| Hypercholesterolemia | 1 | 2021 | 38 | 0.710 |
Why?
| Cryosurgery | 1 | 2021 | 36 | 0.690 |
Why?
| Systole | 4 | 2023 | 72 | 0.680 |
Why?
| Male | 34 | 2025 | 26761 | 0.680 |
Why?
| Magnetic Resonance Imaging, Cine | 3 | 2016 | 62 | 0.670 |
Why?
| Operative Time | 2 | 2017 | 77 | 0.660 |
Why?
| Heart | 2 | 2021 | 345 | 0.650 |
Why?
| Dyspnea | 3 | 2018 | 78 | 0.650 |
Why?
| Aged | 22 | 2025 | 10121 | 0.650 |
Why?
| Digitalis | 1 | 2019 | 5 | 0.650 |
Why?
| Predictive Value of Tests | 10 | 2022 | 944 | 0.640 |
Why?
| Anticoagulants | 3 | 2022 | 270 | 0.640 |
Why?
| Middle Aged | 24 | 2025 | 13028 | 0.610 |
Why?
| Female | 30 | 2025 | 28171 | 0.590 |
Why?
| Cardiac Catheters | 1 | 2018 | 11 | 0.590 |
Why?
| Auscultation | 1 | 2018 | 9 | 0.580 |
Why?
| Heart Murmurs | 1 | 2018 | 14 | 0.580 |
Why?
| Asymptomatic Diseases | 1 | 2018 | 38 | 0.580 |
Why?
| Time Factors | 9 | 2022 | 2968 | 0.560 |
Why?
| Drug Prescriptions | 1 | 2018 | 102 | 0.550 |
Why?
| Coronary Disease | 2 | 2015 | 152 | 0.550 |
Why?
| Heart Diseases | 2 | 2017 | 216 | 0.550 |
Why?
| Artifacts | 1 | 2017 | 55 | 0.550 |
Why?
| Peripheral Arterial Disease | 1 | 2018 | 75 | 0.540 |
Why?
| Mediastinal Neoplasms | 1 | 2017 | 18 | 0.530 |
Why?
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2018 | 145 | 0.530 |
Why?
| Hospital Mortality | 2 | 2018 | 435 | 0.530 |
Why?
| Coronary Occlusion | 1 | 2017 | 79 | 0.520 |
Why?
| Surgical Procedures, Operative | 1 | 2017 | 64 | 0.510 |
Why?
| Absorbable Implants | 1 | 2016 | 13 | 0.510 |
Why?
| Tomography, Optical Coherence | 1 | 2017 | 109 | 0.510 |
Why?
| Acute Coronary Syndrome | 1 | 2017 | 80 | 0.490 |
Why?
| Pneumonia | 1 | 2017 | 125 | 0.490 |
Why?
| Propafenone | 1 | 2015 | 2 | 0.490 |
Why?
| Tachycardia, Ectopic Atrial | 1 | 2015 | 3 | 0.480 |
Why?
| Flecainide | 1 | 2015 | 4 | 0.480 |
Why?
| Respiratory Insufficiency | 1 | 2017 | 120 | 0.480 |
Why?
| Heart Conduction System | 1 | 2015 | 24 | 0.480 |
Why?
| Hypoparathyroidism | 1 | 2015 | 5 | 0.480 |
Why?
| Hypocalcemia | 1 | 2015 | 13 | 0.470 |
Why?
| Rhabdomyolysis | 1 | 2015 | 12 | 0.470 |
Why?
| Prognosis | 6 | 2024 | 2099 | 0.470 |
Why?
| Heart Rate | 2 | 2021 | 318 | 0.470 |
Why?
| Clinical Competence | 1 | 2018 | 406 | 0.460 |
Why?
| Thyroidectomy | 1 | 2015 | 61 | 0.450 |
Why?
| Cardiac Surgical Procedures | 2 | 2017 | 321 | 0.450 |
Why?
| Physician-Patient Relations | 1 | 2015 | 143 | 0.430 |
Why?
| Heart Neoplasms | 1 | 2014 | 32 | 0.430 |
Why?
| Fibroma | 1 | 2014 | 40 | 0.430 |
Why?
| Ventricular Function, Left | 4 | 2019 | 172 | 0.420 |
Why?
| Recurrence | 4 | 2021 | 672 | 0.420 |
Why?
| Theophylline | 1 | 2013 | 17 | 0.420 |
Why?
| Syncope | 1 | 2013 | 30 | 0.410 |
Why?
| Diabetes Mellitus, Type 2 | 4 | 2022 | 560 | 0.400 |
Why?
| Physicians | 1 | 2015 | 241 | 0.380 |
Why?
| Heart Valve Prosthesis | 2 | 2022 | 86 | 0.360 |
Why?
| Heart Valve Prosthesis Implantation | 2 | 2022 | 96 | 0.360 |
Why?
| Stroke Volume | 3 | 2025 | 155 | 0.350 |
Why?
| Amyloidosis | 3 | 2016 | 85 | 0.350 |
Why?
| Octreotide | 1 | 2010 | 9 | 0.330 |
Why?
| Sulfonylurea Compounds | 1 | 2010 | 6 | 0.330 |
Why?
| Arkansas | 6 | 2019 | 2028 | 0.330 |
Why?
| Benzocaine | 1 | 2009 | 4 | 0.330 |
Why?
| Ventricular Remodeling | 3 | 2021 | 64 | 0.320 |
Why?
| Head and Neck Neoplasms | 1 | 2013 | 288 | 0.320 |
Why?
| Methemoglobinemia | 1 | 2009 | 5 | 0.320 |
Why?
| Hypoglycemia | 1 | 2010 | 59 | 0.310 |
Why?
| Echocardiography, Transesophageal | 1 | 2009 | 60 | 0.310 |
Why?
| Diagnosis, Differential | 3 | 2018 | 1046 | 0.310 |
Why?
| Anesthetics, Local | 1 | 2009 | 79 | 0.310 |
Why?
| Prospective Studies | 3 | 2023 | 2481 | 0.290 |
Why?
| Prosthesis Design | 3 | 2022 | 256 | 0.290 |
Why?
| Vasodilator Agents | 2 | 2022 | 96 | 0.290 |
Why?
| Reproducibility of Results | 3 | 2025 | 1229 | 0.280 |
Why?
| Myocardial Contraction | 2 | 2019 | 112 | 0.280 |
Why?
| Incidence | 5 | 2019 | 1062 | 0.280 |
Why?
| Coronary Vessels | 2 | 2020 | 166 | 0.260 |
Why?
| Chronic Disease | 3 | 2018 | 586 | 0.260 |
Why?
| Pressure | 2 | 2017 | 104 | 0.250 |
Why?
| Defibrillators, Implantable | 2 | 2019 | 69 | 0.250 |
Why?
| Ventricular Outflow Obstruction | 1 | 2025 | 26 | 0.240 |
Why?
| Randomized Controlled Trials as Topic | 5 | 2022 | 595 | 0.230 |
Why?
| Follow-Up Studies | 5 | 2019 | 2279 | 0.230 |
Why?
| Cardiomyopathies | 2 | 2016 | 121 | 0.230 |
Why?
| Foramen Ovale, Patent | 2 | 2015 | 31 | 0.230 |
Why?
| Cardiac Catheterization | 3 | 2022 | 232 | 0.220 |
Why?
| Blood Transfusion | 1 | 2025 | 127 | 0.220 |
Why?
| Myxoma | 1 | 2024 | 18 | 0.220 |
Why?
| Hepatitis C, Chronic | 2 | 2015 | 86 | 0.220 |
Why?
| Adult | 9 | 2025 | 14161 | 0.210 |
Why?
| Hospitalization | 4 | 2022 | 736 | 0.200 |
Why?
| Risk Assessment | 4 | 2022 | 1327 | 0.200 |
Why?
| Mitral Valve Insufficiency | 1 | 2022 | 52 | 0.190 |
Why?
| Bioprosthesis | 1 | 2022 | 40 | 0.190 |
Why?
| Electrodes | 1 | 2022 | 35 | 0.190 |
Why?
| Proportional Hazards Models | 3 | 2020 | 443 | 0.190 |
Why?
| Warfarin | 1 | 2022 | 84 | 0.180 |
Why?
| Pilot Projects | 2 | 2022 | 721 | 0.180 |
Why?
| Multiple Myeloma | 4 | 2017 | 3049 | 0.180 |
Why?
| Glycosides | 1 | 2020 | 19 | 0.180 |
Why?
| Sodium-Glucose Transporter 1 | 1 | 2020 | 6 | 0.180 |
Why?
| Severity of Illness Index | 2 | 2018 | 1026 | 0.180 |
Why?
| Microscopy, Fluorescence, Multiphoton | 1 | 2020 | 7 | 0.180 |
Why?
| Vasodilation | 1 | 2021 | 99 | 0.180 |
Why?
| Tachycardia, Supraventricular | 1 | 2021 | 37 | 0.170 |
Why?
| Cardiovascular System | 1 | 2020 | 53 | 0.170 |
Why?
| Calcinosis | 1 | 2020 | 51 | 0.170 |
Why?
| United States | 3 | 2022 | 5192 | 0.170 |
Why?
| United States Department of Veterans Affairs | 1 | 2022 | 293 | 0.170 |
Why?
| Blood Pressure | 1 | 2022 | 537 | 0.160 |
Why?
| Digoxin | 1 | 2019 | 29 | 0.160 |
Why?
| Heart Failure, Systolic | 1 | 2019 | 7 | 0.160 |
Why?
| Electric Stimulation Therapy | 1 | 2019 | 23 | 0.160 |
Why?
| Inpatients | 2 | 2018 | 205 | 0.160 |
Why?
| Metoprolol | 1 | 2019 | 13 | 0.150 |
Why?
| Cardiotonic Agents | 1 | 2019 | 82 | 0.150 |
Why?
| Platelet Transfusion | 1 | 2018 | 33 | 0.150 |
Why?
| Kaplan-Meier Estimate | 2 | 2017 | 483 | 0.150 |
Why?
| Cerebrovascular Disorders | 1 | 2018 | 48 | 0.150 |
Why?
| Hepatitis C Antibodies | 2 | 2015 | 19 | 0.150 |
Why?
| Delivery of Health Care | 1 | 2021 | 323 | 0.140 |
Why?
| Databases, Factual | 2 | 2018 | 706 | 0.140 |
Why?
| Renal Insufficiency, Chronic | 1 | 2020 | 187 | 0.140 |
Why?
| Cardiovascular Diseases | 3 | 2020 | 490 | 0.140 |
Why?
| Cardiac Imaging Techniques | 1 | 2017 | 9 | 0.140 |
Why?
| Fever | 1 | 2018 | 112 | 0.140 |
Why?
| Logistic Models | 2 | 2017 | 925 | 0.140 |
Why?
| Hepacivirus | 2 | 2015 | 106 | 0.140 |
Why?
| Cell Transdifferentiation | 1 | 2017 | 8 | 0.140 |
Why?
| Xanthine Oxidase | 1 | 2017 | 14 | 0.140 |
Why?
| Foam Cells | 1 | 2017 | 17 | 0.130 |
Why?
| Hemorrhage | 1 | 2018 | 209 | 0.130 |
Why?
| Respiratory Sounds | 1 | 2017 | 50 | 0.130 |
Why?
| Survival Rate | 2 | 2019 | 945 | 0.130 |
Why?
| Cohort Studies | 2 | 2018 | 1542 | 0.130 |
Why?
| Myocytes, Smooth Muscle | 1 | 2017 | 93 | 0.130 |
Why?
| Radiographic Image Enhancement | 1 | 2016 | 29 | 0.130 |
Why?
| Gadolinium DTPA | 1 | 2016 | 25 | 0.130 |
Why?
| Chi-Square Distribution | 1 | 2017 | 288 | 0.130 |
Why?
| Propensity Score | 1 | 2017 | 154 | 0.130 |
Why?
| Inflammasomes | 1 | 2017 | 66 | 0.130 |
Why?
| Muscle, Smooth, Vascular | 1 | 2017 | 133 | 0.130 |
Why?
| Kidney | 1 | 2020 | 707 | 0.130 |
Why?
| Quality Improvement | 1 | 2018 | 226 | 0.120 |
Why?
| Magnetic Resonance Imaging | 3 | 2024 | 1546 | 0.120 |
Why?
| Voltage-Gated Sodium Channel Blockers | 1 | 2015 | 5 | 0.120 |
Why?
| Intermittent Claudication | 1 | 2015 | 13 | 0.120 |
Why?
| Ventricular Function | 1 | 2015 | 19 | 0.120 |
Why?
| Fundoplication | 1 | 2015 | 20 | 0.120 |
Why?
| Goiter | 1 | 2015 | 4 | 0.120 |
Why?
| Postpericardiotomy Syndrome | 1 | 2015 | 4 | 0.120 |
Why?
| Immobilization | 1 | 2015 | 15 | 0.120 |
Why?
| Supine Position | 1 | 2015 | 28 | 0.120 |
Why?
| Pericardiectomy | 1 | 2015 | 6 | 0.120 |
Why?
| Healthcare Disparities | 1 | 2018 | 299 | 0.120 |
Why?
| Colchicine | 1 | 2015 | 24 | 0.120 |
Why?
| Length of Stay | 1 | 2018 | 663 | 0.120 |
Why?
| Pericarditis | 1 | 2015 | 20 | 0.120 |
Why?
| Mucolipidoses | 1 | 2014 | 4 | 0.120 |
Why?
| Aged, 80 and over | 3 | 2018 | 3392 | 0.120 |
Why?
| Scavenger Receptors, Class E | 1 | 2017 | 204 | 0.110 |
Why?
| Secondary Prevention | 1 | 2015 | 84 | 0.110 |
Why?
| Carcinoma, Renal Cell | 1 | 2015 | 111 | 0.110 |
Why?
| Thoracotomy | 1 | 2014 | 33 | 0.110 |
Why?
| Sulfonamides | 1 | 2015 | 133 | 0.110 |
Why?
| Obesity, Morbid | 1 | 2015 | 87 | 0.110 |
Why?
| Septal Occluder Device | 1 | 2014 | 36 | 0.110 |
Why?
| Pyrimidines | 1 | 2015 | 199 | 0.110 |
Why?
| Kidney Neoplasms | 1 | 2015 | 182 | 0.100 |
Why?
| Bone Marrow Transplantation | 1 | 2014 | 113 | 0.100 |
Why?
| Laparoscopy | 1 | 2015 | 180 | 0.100 |
Why?
| Mitral Valve | 2 | 2022 | 52 | 0.100 |
Why?
| Prosthesis Failure | 2 | 2022 | 111 | 0.090 |
Why?
| Administration, Oral | 1 | 2013 | 451 | 0.090 |
Why?
| Tomography, X-Ray Computed | 1 | 2017 | 1165 | 0.090 |
Why?
| Postoperative Complications | 2 | 2015 | 1068 | 0.090 |
Why?
| Injections, Subcutaneous | 1 | 2010 | 51 | 0.080 |
Why?
| Pericardium | 1 | 2010 | 29 | 0.080 |
Why?
| Gastrointestinal Agents | 1 | 2010 | 41 | 0.080 |
Why?
| Drug Monitoring | 1 | 2010 | 83 | 0.080 |
Why?
| Quality of Life | 1 | 2015 | 879 | 0.080 |
Why?
| Cause of Death | 2 | 2020 | 160 | 0.080 |
Why?
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2015 | 1031 | 0.080 |
Why?
| Lipid Metabolism | 1 | 2010 | 187 | 0.080 |
Why?
| Renal Dialysis | 1 | 2010 | 179 | 0.070 |
Why?
| Kidney Failure, Chronic | 1 | 2010 | 210 | 0.070 |
Why?
| Dose-Response Relationship, Drug | 1 | 2010 | 1378 | 0.060 |
Why?
| Exercise | 1 | 2010 | 547 | 0.060 |
Why?
| Blood Flow Velocity | 1 | 2025 | 95 | 0.060 |
Why?
| Oxidative Stress | 1 | 2010 | 807 | 0.060 |
Why?
| Disease Progression | 2 | 2020 | 871 | 0.060 |
Why?
| RNA, Viral | 2 | 2015 | 127 | 0.060 |
Why?
| Gadolinium | 1 | 2024 | 44 | 0.050 |
Why?
| Heart Atria | 1 | 2024 | 63 | 0.050 |
Why?
| Sensitivity and Specificity | 1 | 2025 | 891 | 0.050 |
Why?
| Vitamin K | 1 | 2022 | 16 | 0.050 |
Why?
| Contrast Media | 1 | 2024 | 193 | 0.050 |
Why?
| American Heart Association | 1 | 2022 | 32 | 0.050 |
Why?
| Telemetry | 1 | 2021 | 29 | 0.050 |
Why?
| Tachycardia | 1 | 2021 | 28 | 0.040 |
Why?
| Glucosides | 1 | 2020 | 23 | 0.040 |
Why?
| Acute Disease | 1 | 2022 | 373 | 0.040 |
Why?
| Platelet Aggregation Inhibitors | 1 | 2022 | 181 | 0.040 |
Why?
| Diabetic Ketoacidosis | 1 | 2020 | 18 | 0.040 |
Why?
| Glomerular Filtration Rate | 1 | 2020 | 124 | 0.040 |
Why?
| Early Diagnosis | 1 | 2020 | 95 | 0.040 |
Why?
| Benzhydryl Compounds | 1 | 2020 | 68 | 0.040 |
Why?
| Exercise Tolerance | 1 | 2019 | 46 | 0.040 |
Why?
| Death, Sudden, Cardiac | 1 | 2019 | 59 | 0.040 |
Why?
| Anti-Arrhythmia Agents | 1 | 2019 | 81 | 0.040 |
Why?
| Recovery of Function | 1 | 2019 | 199 | 0.040 |
Why?
| Oxygen Consumption | 1 | 2019 | 198 | 0.040 |
Why?
| Adrenergic beta-Antagonists | 1 | 2019 | 110 | 0.040 |
Why?
| Feasibility Studies | 1 | 2020 | 406 | 0.040 |
Why?
| Uric Acid | 1 | 2017 | 25 | 0.030 |
Why?
| Scavenger Receptors, Class A | 1 | 2017 | 39 | 0.030 |
Why?
| Referral and Consultation | 1 | 2018 | 292 | 0.030 |
Why?
| Registries | 1 | 2020 | 581 | 0.030 |
Why?
| RNA Interference | 1 | 2017 | 181 | 0.030 |
Why?
| Transfection | 1 | 2017 | 357 | 0.030 |
Why?
| Biopsy, Needle | 1 | 2016 | 183 | 0.030 |
Why?
| Hernia, Hiatal | 1 | 2015 | 9 | 0.030 |
Why?
| ROC Curve | 1 | 2016 | 253 | 0.030 |
Why?
| Disease Models, Animal | 1 | 2020 | 1478 | 0.030 |
Why?
| Mice, Inbred C57BL | 1 | 2020 | 1884 | 0.030 |
Why?
| Gastroesophageal Reflux | 1 | 2015 | 48 | 0.030 |
Why?
| Patient Acceptance of Health Care | 1 | 2018 | 358 | 0.030 |
Why?
| Tubulin Modulators | 1 | 2015 | 27 | 0.030 |
Why?
| Indazoles | 1 | 2015 | 47 | 0.030 |
Why?
| Reactive Oxygen Species | 1 | 2017 | 421 | 0.030 |
Why?
| Seroepidemiologic Studies | 1 | 2014 | 44 | 0.030 |
Why?
| Multivariate Analysis | 1 | 2016 | 591 | 0.030 |
Why?
| Biopsy | 1 | 2016 | 605 | 0.030 |
Why?
| Survival Analysis | 1 | 2016 | 673 | 0.030 |
Why?
| Pneumonectomy | 1 | 2014 | 29 | 0.030 |
Why?
| Angiogenesis Inhibitors | 1 | 2015 | 183 | 0.030 |
Why?
| Myocardium | 1 | 2016 | 453 | 0.030 |
Why?
| Prosthesis Implantation | 1 | 2014 | 51 | 0.030 |
Why?
| Posture | 1 | 2014 | 66 | 0.030 |
Why?
| Anti-Inflammatory Agents | 1 | 2015 | 166 | 0.030 |
Why?
| Age Distribution | 1 | 2013 | 174 | 0.030 |
Why?
| Polymerase Chain Reaction | 1 | 2014 | 461 | 0.030 |
Why?
| Syndrome | 1 | 2014 | 247 | 0.030 |
Why?
| Immunohistochemistry | 1 | 2016 | 979 | 0.030 |
Why?
| Ventricular Dysfunction, Left | 1 | 2014 | 108 | 0.020 |
Why?
| Cell Line, Tumor | 1 | 2017 | 1470 | 0.020 |
Why?
| Transplantation, Autologous | 1 | 2014 | 488 | 0.020 |
Why?
| Comorbidity | 1 | 2013 | 625 | 0.020 |
Why?
| Oxygen | 1 | 2014 | 336 | 0.020 |
Why?
| alpha-2-HS-Glycoprotein | 1 | 2010 | 2 | 0.020 |
Why?
| Thiobarbituric Acid Reactive Substances | 1 | 2010 | 11 | 0.020 |
Why?
| Signal Transduction | 1 | 2017 | 1671 | 0.020 |
Why?
| Blood Proteins | 1 | 2010 | 85 | 0.020 |
Why?
| C-Reactive Protein | 1 | 2010 | 155 | 0.020 |
Why?
| Interleukin-6 | 1 | 2010 | 278 | 0.020 |
Why?
| Lung Neoplasms | 1 | 2014 | 636 | 0.020 |
Why?
| Animals | 1 | 2020 | 13505 | 0.020 |
Why?
| Young Adult | 1 | 2013 | 4329 | 0.010 |
Why?
| Adolescent | 1 | 2013 | 6739 | 0.010 |
Why?
|
|
Vallurupalli's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|